Editorial Board
Fudan University, USA
| Biography Dr. Yongjie Zhou received her M.D. at Shanghai Medical College, Fudan University, Shanghai, China in 1982, and her Ph.D. degree at Baylor College of Medicine, Houston, Texas, USA in 1995. She has conducted medical research for about 20 years to understand the molecular epidemiology of human rotaviruses-mediated diseases, rotavirus assembly and replication, hepatitis C virus replication, and the roles of protein tyrosine kinases in cytokine-mediated signaling and immune regulations. Her research has also involved in development of viral vaccine and immunosuppressive drugs. She is currently a Biologist at the U.S. Food and Drug Administration. Research Interest
|  |
President: European Society for Virology, Italy
| Biography
Dr. Giorgio Palu is the serving President of European Society for Virology and Director of the Department of Molecular Medicine, University of Padova, Italy and (since 2012). His advisory positions include Italian Drug Agency (AIFA); Higher Italian Council for Health; Ministry of Health, biomedical research; Italian National Institute of Health and many more. Research Interest
|  |
Institut Pasteur, Paris, France
| Biography Dr Jean-Pierre Vartanian is an associated professor at Institut Pasteur in Paris, France and co-director of virological courses at Institut Pasteur. He received his Ph.D degree in virology from Paris-Diderot University in 1992. He has over 25 years of research experience in virology. He is specialised in retroviruses and by innate cellular factorsin restricting intracellular viral replication (HIV, HBV). Research Interest
|  |
UCLA, USA
| Biography Dr. Hong Z. Zhou is a professor in the Department of Microbiology, Immunology and Molecular Genetics at the UCLA David Geffen School of Medicine and the founding director of the UCLA Electron Imaging Center for NanoMachines. He obtained his Ph.D from BaylorCollege of Medicine, Houston, TX. He has extensive experience in developing high-resolution cryoEM methods, and improving 3D reconstruction algorithms and speed for determining structure to atomic resolution. He has authored or co-authored a total of 127 papers/chapters. Research Interest
|  |
University of Nebraska Medical Center, USA
| Biography Dr. Santhi Gorantla is an Assistant Professor in the Department of Pharmacology and Experiment Neuroscience at University of Nebraska Medical Center (UNMC), Omaha, NE. She got her first postdoctoral training in Gene therapy strategies for HIV in humanized mouse models at Colorado State University, and her second postdoctoral training was on the HIV-1 induced neuropathogenesis in humanized mouse models and immune modulatory therapeutic approaches. She has published more than 30 peer reviewed journal articles and contributed to five book chapters. Currently her work is funded by National Institute of Health and Nebraska Stem Cell grants. Research Interest
|  |
Ohio Department of Agriculture, USA
| Biography Dr. Leyi Wang is a researcher in the Animal Disease Diagnostic Laboratory of Ohio Department of Agriculture. He received his DVM at Shandong Agricultural University in 2001 and his Ph.D. degree in virology at Ohio State University in 2009. Dr. Wang has conducted development of different platforms of vaccines against different viruses for over 10 years. He also conducts identification of new emerging viruses including the variant porcine epidemic diarrhea virus and porcine deltacoronavirus. Research Interest
|  |
Director, Immunobiology of HIV Unit, San Raffaele Scientific Institute, Italy
| Biography
Lucia Lopalco obtained her degree in Biological Science in 1982 in Immunology and Microbiology at University of Pavia, Italy. She carried out her post-doctoral training at the Department of Immunology and Microbiology, University of Veterinary Medicine, Milan, Italy till 1986. Then she moved to the Department of Biology and Genetic for Medical Science, University of Milan, Italy. Research Interest
|  |
Institute of Virology, University Medical Center, Germany
| Biography
Dr. Ahmed Studied veterinary medicine at Mansoura University, Egypt, 2002. He Received his PhD in biology from Gottingen University, Germany March 2011. PhD thesis entitled (use of peptide microarrays for mapping viral B cell epitopes) Research Interest
peptidepeptide microarray, point-of-care diagnostics (microfluidic system),
DNA and RNA quantification microarray, point-of-care diagnostics (microfluidic system),
recombinase polymerase amplification assay, convention and real
time polymerase chain reaction, primer and probe design, TA cloning,
DNA and RNA quantification
|  |
Institute of Molecular Biology, National Chung Hsing University, Taiwan
| Biography Hung-Jen Liu is a distinguished professor and Director of Institute of Molecular Biology at National Chung Hsing University, Taiwan. He completed his DVM degree in the department of Veterinary Medicine at National Pingtung University of Science and Technology, Taiwan. He received his Ph.D degree from Auburn University, USA in 1996 and completed his postdoctoral training in 1997 from Manitoba University School of Medicine, Canada. He is particularly interested in the studying virus and host interaction and development of subunit vaccines using a baculovirus display system.He published more than 148 peer-review papers, book chapters, and patents. Research Interest
|  |
Brunel University, UK
| Biography Dr Themis is head of the Gene Therapy and Genotoxicity Group at Brunel University. His work resulted in the first correction of the KO FIX mouse model for haemophilia B using in utero gene transfer and partial correction of this model using ex-vivo stem cell gene therapy. He has also developed genotoxicity models that provide highly sensitive tests for gene therapy vector adverse effects and identify novel genes that cause cancer. He is currently studying the relationship between retrovirus vectors and exosomes generated from FRDA cells that contain RNAs related to gene correction and control of FXN expression, respectively. He is a member of the Breast Cancer Campaign SAB, and a founder member of the British Society for Gene Therapy. Research Interest
|  |
Saitama Medical University, Saitama, Japan
| Biography Dr. Tetsuya Uchida was born at Urawa-city, Saitama-prefecture, Japan on March 8, 1953. He received education at local elementary school, junior high school, and high school, and then entered to The University of Tokyo on April 1, 1971. Obtained doctor degree on March 29, 1985 at School of Medicine, The University of Tokyo. During the course of Graduated school at The University of Tokyo, studied abroad for one and a half years (May, 1982 to November, 1983) at Department of Pathology, Harvard Medical School (Dr. Martin E. Dorf) as a Research Fellow. On April 1, 1985, employed by Japanese government at National Institute of Health (Currently National Institute of Infectious Diseases, Japan) and served as a senior investigator till March 31, 2013. On April 1, 2013, moved to Saitama Medical University, School of Medicine as a Professor at Department of Microbiology (Present position). Research Interest
|  |
California Northstate University College of Medicine, USA
| Biography Liljana Stevceva is a Professor of Immunology and College Master at California Northstate University College of Medicine. She holds a medical degree from the University Kiril I Metodi, Skopje, Macedonia and a PhD from John Curtin School of Medical Research, Australian National University. In 2000, she was awarded Fogarty International Fellowship and continued her work on HIV pathogenesis and vaccine development at the National Cancer Institute, NIH. Dr. Stevceva serves as a reviewer for 17 international, peer-reviewed journals, three granting agencies and four international conferences. Research Interest
|  |
NIH/NICHD,
| Biography
Petr Chlanda received his M.S. in Biochemistry at Charles University in Prague, Czech Republic and Ph.D. in Virology at the University of Heidelberg, Germany. During his PhD he mastered virology methods, as well as a variety of electron microscopy techniques, including cryo-electron microscopy, which he employed touncover a novel step in the assembly of vaccinia virus or elucidate or reveal the complex mechanism of vaccinia virus assembly or shed light on the assembly of Vaccinia virus. His research revealed role of influenza structural proteins in different budding stages as initiation, elongation and budding neck formation. Research Interest
|  |
University of Lyon, France
| Biography
Dr Caroline Leroux is DR2 (Director of Research, tenure position) at the INRA, the French Institute for Agronomical Research. She received her PhD in Virology from the University Lyon 1 in 1995. She developed her expertise on animal retroviruses and the associated mechanisms leading to the development and progression of the associated diseases. She has an wide expertise on the lung diseases associated with retroviral infection and has developed with her colleagues some pertinent in vitro system using primary pulmonary cells to study the interaction between the virus and the cells.During her post doc, she worked as a research associate in the group of Pr RC Montelaro, (Molecular Genetics and Biochemistry department, Pittsburgh PA USA). Research Interest
|  |
National Center for AIDS/STD Control and Prevention, China-CDC, China
| Biography Gui-Bo Yang is graduated from Sichuan University in 1988. He obtained an MS from KIZ, Academia Sinica in 1991 and a PhD from Peking University in 1994. He did post-doctoral work in Institute of Microbiology and Epidemiology thereafter and worked in Bristol University, Harvard University, and Tulane University during years 1999 to 2003 as a visiting scholar. He also served as an Associate Professor at Beijing Normal University during 1997 to 2001 and has been serving as a Full Professor at National Center for AIDS/STD Control and Prevention of China-CDC since 2004. Research Interest
|  |
Cape Peninsula University of Technology, South Africa
| Biography Prof Oluwafemi Oguntibeju is an Associate Professor and Group Leader (Nutrition and Chronic Disease Research Unit) at the Oxidative Stress Research Centre, Department of Biomedical Sciences, Faculty of Health & Wellness Sciences, Cape Peninsula University of Technology Bellville Campus, South Africa. Over the years, he has been involved in the field of nutrition/HIV and AIDS and related-public health issues but more recently on natural products and health (Phytomedicine). He has successfully supervised 17 masters and 2 doctoral students and currently supervising 4 doctoral and two masters’ students at various stages of their programmes. Prof Oguntibeju has also supervised one post-doctoral research fellow and published over 90 scientific papers in peer-reviewed journals, 9 chapters in books, 7 chapters in press, editor of two books on diabetes. He has received various awards such as the Gold Research Excellence Award at his current university. He is registered with the South African Council for Scientific Professions as a Professional Natural Scientist (Pri.Sc.Nat). Research Interest
|  |
University of West Indies, Jamaica
| Biography Dr Louboutin, MD, PhD, is a Neurologist interested in the neuropathogenesisof HIV-1. By developing different animal models of HIV-1 Associated Neurocognitive Disorder (HAND), he focused his work on the deleterious effects of HIV-1 envelope glycoprotein gp120 and non-structural protein Tat in the brain (apoptosis, oxidative stress, neuroinflammation, abnormalities of the blood-brain barrier, upregulation of MMPs). He is currently in Jamaica trying to get a better understanding of the physiopathology of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). Finally, he is involved in viral-based gene transfer/gene therapy in different tissues (i.e., bone marrow stem cells, skeletal muscle, brain) and the interaction with regenerative medicine in a translational context. He is the author of more than 80 papers in peer-reviewed journals. Research Interest
|  |
Institut Pasteur, France
| Biography Francesca Di Nunzio joined the Pasteur Institute, in October 2009, She was interested to study the HIV nuclear import and the viral integration in the host chromosomal genome. Recently She published that cellular factors, such as TNPO3, Nup358/RanBP2, Nup153, involved in early steps of HIV infection and that bind HIV CA help the HIV-1 to target intragenic regions of chromosomes during integration. She has strong background in virology and in HIV integration field. She worked on ambitious projects in Dr. Engelman’s lab at DFCI & Harvard Medical School, Boston, USA, based on HIV-1 integration in the host genome. She developed lentiviral vectors for gene therapy of genetic diseases, currently in clinical development. Research Interest
|  |
Institute of Molecular Genetics, Czech Republic
| Biography Dr. Jan Svoboda is the founding member of the European Tumour Virus Group (London 1962). He attended and gave papers at almost all of its 16 meetings, with the exception of an involuntary and enforced break in the 1970-ties. In 1967, he co-organized under the sponsorship of the UICC the first international meeting on the Induction of Viruses by Cell Fusion at the Wistar Institute, Philadelphia, PA. In 1988, he organized a symposium and a workshop at the International Congress of Biochemistry in Prague and gave a lecture. Over the years he have presented innumerable papers at specialized symposia, as in part documented by the list of publications. He presented the Howard Temin Memorial Lecture: "An Avian Retrovirologist´s View of Human Carcinogenesis" at the XXII. IACRLRD (International Association for Comparative Research on Leukemia and Related Diseases) Symposium: "From molecular pathogenesis to targeted therapy in leukemia and solid tumors" 2007, at Freiburg, Germany. In 2008 He gave the 3rd Memorial Zilber Lecture: "Retroviruses: past and present" at the Engelhardt Institute of Molecular Biology in Moscow, Russia and I gave the key- note lecture: at the CSHS Symposium: "Retroviruses", N.Y., USA. Research Interest
|  |
Laboratory of Infectious Diseases , USA
| Biography Dr. Xiang Liu received his Ph.D. degree at Peking University, Beijing, China and currently work at National Institutes of Health, US. He has conducted medical research to understand the molecular epidemiology of human rotaviruses-mediated diseases, viral innate immune antagonists, RNA sensing of host cells, and RNA silencing suppressor during viral replication. His research has also involved in development of viral vaccine and investigation of the mechanism of virus infection-induced tumorigenesis. Research Interest
|  |
University of Sciences, Techniques and Technologies of Bamako, West Africa
| Biography Dr.MAIGA, Almoustapha Issiaka is the head of Molecular and Epidemiology of HIV drug resistance laboratory at the University of Sciences Techniques and Technolgies of Bamako and head of Clinical laboratory in the teaching hospital of Gabriel Toure in Bamako. He had an experience with the National AIDS Program in Mali, with Solthis (French NGO which played a key role in HIV biological and clinical monitoring in Segou) and with Esther. During his PhD in virology at the university of Pierre and Marie-Curie, He implemented the HIV drug resistance in the laboratory at University of Bamako. This lab was funded by many partners such as Northwestern University of Chicago, Solthis, Esther (French Agency for resources limited setting) and the National AIDS program in Mali. He is a biological focus point of HIV and TB in the Teaching Hospital of Gabriel Toure. He is a Researcher of the NIH/Fogarty Center AIDS International Training and Research Program (AITRP) based in Mali and Nigeria, and was trained and in Northwestern University virology laboratory. Research Interest
|  |
University of Maryland, USA
| Biography Dr. Toapanta obtained his M.D. degree from the Universidad Central del Ecuador (Quito - Ecuador) and as a member of the “Corporacion Ecuatoriana de Biotecnologia” . He participated in various translational research projects that studied the relationship between micronutrient deficiencies (e.g., Vitamin A and Zinc) and the susceptibility to infectious diseases. He persued his Ph.D. from the University of Pittsburgh (Pittsburgh, PA - USA) and his research focused on understanding the mechanisms by which the final degradation product of the third component of complement (C3d) performs its adjuvant effect. He completed his first post-doctoral training at the Center for Vaccine Research of the University of Pittsburgh and his research focused on novel vaccine design for influenza virus using various platforms such as virus-like particles and DNA vaccines. He joined the Center for Vaccine Development of the University of Maryland as a post-doctoral fellow and was quickly promoted to the faculty ranks as a Research Associate. At the University of Maryland, his research has focused on translational immunology, trying to understand the main immune effector cells elicited by mucosal and systemic vaccines and their overall role in protection from disease. Research Interest
|  |
University of Nebraska Medical Center, USA
| Biography Dr.Pendyala’s research focuses on using an integrated systems biology approach to understand synaptic alterations in neurodegenerative and neurodevelopmental disorders. After his graduate study in 2005 from the University of Fribourg, Switzerland. He performed his Post Doctoral studies at The Scripps Research Institute La Jolla, CA and later at the University of Nebraska Medical Center, Omaha where he has successfully used ‘omics’ based genomics, mass spectrometry coupled proteomics and metabolomics approaches to identify disease specific pathogenic markers for neuroAIDS and drugs of abuse using the non-human primate model. In addition to these, he has also studied the pathogenesis of Amyotrophic Lateral Sclerosis (ALS) and was supported by the prestigious Milton Safenowitz Post Doctoral fellowship awarded by The ALS Association. Apart from his publications in reputed journals, he also serves as reviewer for several peer-reviewed journals including as an Academic Editor for PLoS One. Research Interest
|  |
Johns Hopkins University School of Medicine., China
| Biography
Dr. Lixin Dai obtained his bachelor and master degrees in Biochemistry from Nankai University, China and Ph.D. degree from University of Calgary, Canada. During Ph.D. study, he studied the distribution and three-dimensional structure of a catalytic RNA – group II intron. Currently he is a research associate in the Department of Molecular Biology and Genetics at Johns Hopkins University School of Medicine. Research Interest
|  |
Baylor College of Medicine, Houston, USA
| Biography
Dr. Manish's work focuses on studying these different infectious diseases and explores new methodologies and pathways for their prevention and control which requires an early diagnosis of infectious agent, understanding of host responses against these microorganisms, and development of Vaccines and antimicrobials as the most significant strategies to fight against these infections. His PhD work focused on this early diagnosis of the fungal infection of the eye, whereby he developed a DNA based assay technique to diagnose these infections in very early phase.Recently he have found adenovirus induce cancer utilizing two cellular proteins PI3K and PTEN. Thus his studies with adenovirus are not only contributing to understand its pathogenesis but they also lead to cancer prevention and treatment. Research Interest
|  |
Ohio State University, USA
| Biography Dr. Hui Cai, received his master degree in Bioinformatics and Ph.D. in microbiology from Wuhan University, China. He is currently working at the Department of Veterinary Biosciences of the Ohio State University, US. During his Ph.D. period, he worked on the capping mechanism of SARS-CoV, and verified SARS-CoV nsp14 as a N7-methyltransferase with a unique combination with exo-nuclease activity. From 2009 to 2011 he worked on screening antiviral compounds inhibiting HCV RdRp NS5B, and combining bioinformatics and biochemical methods to understand activation mechanism of RIG-I. Since 2011, he changed his interest to investigate the RNA transcription and capping mechanism of Human Metapneumovirus (hMPV) and Porcine Epidemic Diarrhea Virus (PEDV). With successfully identified hMPV M2-1 as a zinc binding protein, he verified abolishing zinc binding motif is a reasonable strategy to generate live attenuated vaccine. Research Interest
|  |
University of Milano, Italy
| Biography Dr. Serena Delbue is assistant professor of Microbiology and Virology at the University of Milano, Milano, Italy, and adjunct assistant professor at the Department of Neuroscience, Temple University, Philadelphia, PA, USA. She is author and coauthors of 70 peer reviewed papers published on international journals and her current h-index is 16. She is the senior supervisor of the Laboratory of Translational Research at the University of Milano, that is directed by prof. Pasquale Ferrante, and is involved in several research projects devoted to the study of the molecular basis of the human polyomaviruses related diseases, with a special focus on the Polyomaviruses JC and BK. Additionally, she has been working for several years on the opportunistic infections in HIV positive patients. Research Interest
|  |
Weill Cornell Medical College of Cornell University, US
| Biography Dr. Junji Xing received his Ph.D. at Wuhan Institute of Virology, Chinese Academy of Sciences. During his Ph.D. studies, his research focuses on elucidating the molecular mechanism of host innate immune evasion by herpes simplex virus 1 (HSV-1), interactions of virus and host cells, subcellular transport mechanism of viral proteins in host cells. As a postdoc associate in University of Minnesota, he investigated the mechanisms of immune suppression and pathogenesis by Arenaviruses in human primary cells or guinea pig animal model. As a research associate in Houston Methodist Research Institute affiliated with Weill Cornell Medicine of Cornell University, his research is now involved in charactering the roles of TRIM family protein in host innate immunity regulation. Research Interest
|  |
